chuminhua2020-06-01 20:30
5/30,Menlo Therapeutics公司$Menlo Therapeutics(MNLO)$ 宣布,美国FDA已批准其全资子公司Foamix Pharmaceuticals开发的米诺环素局部疗法Zilxi(1.5% minocyline,FMX103)上市,治疗酒渣鼻成人患者。新闻稿指出,Zilxi是首款获得美国FDA批准治疗酒渣鼻成人患者的米诺环素局部疗法。Zilxi是该公...查看全文
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-08-01 AccNo: 0001564590-19-027977 Size: 147 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Menlo Therapeutics(MNLO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-01 AccNo: 0001564590-19-027984 Size: 6 MB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-06-27 AccNo: 0001564590-19-023830 Size: 41 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-06-06 AccNo: 0001564590-19-021913 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Menlo Therapeutics(MNLO)$ DEF 14A - Other definitive proxy statements Filed: 2019-05-10 AccNo: 0001564590-19-018528 Size: 1 MB 网页链接
$Menlo Therapeutics(MNLO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2019-05-10 AccNo: 0001564590-19-018540 Size: 132 KB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-05-02 AccNo: 0001564590-19-015344 Size: 116 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Menlo Therapeutics(MNLO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-02 AccNo: 0001564590-19-015358 Size: 5 MB 网页链接
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-04-24 AccNo: 0001564590-19-012607 Size: 38 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Menlo Therapeutics(MNLO)$ 8-K - Current report Filed: 2019-04-22 AccNo: 0001564590-19-012274 Size: 23 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接